Literature DB >> 24195744

Dermis fat grafts as primary and secondary orbital implants.

Martin M Nentwich1, Kirsten Schebitz-Walter, Christoph Hirneiss, Christoph Hintschich.   

Abstract

INTRODUCTION: This study was performed to evaluate the outcome after autologous dermis-fat graft [DFG] orbital implants in a large sample.
MATERIALS AND METHODS: A retrospective chart review of all primary and secondary DFGs in a 16-year period was done. Aesthetic and functional results, patients' satisfaction and postoperative complications were evaluated.
RESULTS: In total 468 DFGs were performed in the study period (315 primary [I°] and 153 secondary [II°] DGFs). In the analysis, 173 DFG I° and 66 DFG II° were included as sufficient follow-up was available. Median follow-up after DFG I° was 21.5 months and 14 months after DFG II°. After DFG I°, in 76% of patients motility of the graft was possible in all directions; 81% had good fitting of the prosthesis and 83% were highly satisfied with the results. Mean width of palpebral apertures was 0.2 mm smaller and Hertel exophthalmometry revealed a mean enophthalmus of 1.6 mm on the operated side compared to the fellow-eye. After DFG II°, motility was possible in all directions in 34% of patients. Fitting of the prosthesis was good/reasonable in 49%/41% and patients were highly satisfied in 57%. On average, on the operated side palpebral apertures were 0.6 mm smaller and Hertel measurements showed an enophthalmus of 2.6 mm. Major complications were uncommon. Complete necrosis of the implant was more often observed after II° (6.1%) than after I° DFG (3.5%). DISCUSSION: In this large sample, DFG proved to be an effective and safe method for the reconstruction of anophthalmic sockets.

Entities:  

Mesh:

Year:  2013        PMID: 24195744     DOI: 10.3109/01676830.2013.844172

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  9 in total

1.  [Epithelial ingrowth after evisceration].

Authors:  P L Müller; M C Herwig-Carl; F G Holz; K U Loeffler
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

2.  Primary Dermis Fat Grafting for Socket Reconstruction: Retrospective Comparison of Electrocoagulation versus Scalpel Dissection for Epidermis Removal.

Authors:  Mostafa Mohammed Diab; Yomna Amr Alahmadawy
Journal:  Clin Ophthalmol       Date:  2020-09-29

3.  Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.

Authors:  A Klingenstein; C Fürweger; A K Mühlhofer; S F Leicht; U C Schaller; A Muacevic; B Wowra; C Hintschich; K H Eibl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-16       Impact factor: 3.117

4.  Indications and results in anophthalmic socket reconstruction using dermis-fat graft.

Authors:  Orapan Aryasit; Passorn Preechawai
Journal:  Clin Ophthalmol       Date:  2015-05-04

5.  Outcomes of secondary autologus dermo-fat orbital implants in anophthalmic sockets.

Authors:  Nausheen Hayat; Saad Jan; Natasha Atiq; Alyscia Cheema
Journal:  Pak J Med Sci       Date:  2021 Mar-Apr       Impact factor: 1.088

Review 6.  The Evolution of Orbital Implants and Current Breakthroughs in Material Design, Selection, Characterization, and Clinical Use.

Authors:  Xiao-Yi Chen; Xue Yang; Xing-Li Fan
Journal:  Front Bioeng Biotechnol       Date:  2022-02-17

7.  A prospective randomized pilot study evaluating the scar outcome after gluteal dermis fat graft with and without kinesiotaping.

Authors:  Annemarie Klingenstein; Aylin Garip-Kuebler; Daniel R Muth; Christoph Hintschich
Journal:  Int Ophthalmol       Date:  2022-04-02       Impact factor: 2.029

8.  Commentary: Using newer technology for an unresolved clinical dilemma.

Authors:  Raj Anand
Journal:  Indian J Ophthalmol       Date:  2018-11       Impact factor: 1.848

9.  Low-cost three-dimensional printed orbital template-assisted patient-specific implants for the correction of spherical orbital implant migration.

Authors:  Tarjani Vivek Dave; Sweety Tiple; Sandeep Vempati; Mansha Palo; Mohammad Javed Ali; Swathi Kaliki; Milind N Naik
Journal:  Indian J Ophthalmol       Date:  2018-11       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.